ALLR
ALLR
NASDAQ · Biotechnology

Allarity Therapeutics Inc

$0.83
+0.02 (+2.56%)
As of Feb 8, 2:27 PM ET ·
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 2.19M 1.96M 2.40M
Net Income -647,190 -493,473 -738,397
EPS
Profit Margin -29.6% -25.2% -30.8%
Rev Growth +18.0% +10.8% +10.6%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 1.72M 1.54M 1.78M
Total Equity 6.23M 6.69M 6.01M
D/E Ratio 0.28 0.23 0.30
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -712,204 -583,546 -705,797
Free Cash Flow -781,686 -525,232 -735,953